Archive
- twiist automated insulin delivery in type 2 diabetes: 13-week single-arm trialOther study · 10 October 2026
- Semaglutide in diabetic kidney disease: primary MRI outcomes not met in 52-week trialRandomised trial · 10 October 2026
- ADA and EASD 2026 consensus: earlier SGLT2 inhibitor and/or GLP-1-based therapy in type 2 diabetesGuideline · 10 October 2026
- Resmetirom effects in MASH were similar across common risk genotypesOther study · 10 October 2026
- Oral safiglipron versus dapagliflozin in type 2 diabetes: phase 3 trial in ChinaRandomised trial · 10 October 2026
- Chemically synthesised semaglutide HD1916 met equivalence with Wegovy for weight loss in Chinese adultsRandomised trial · 10 October 2026
- Nearly one in four indigenous adults in Odisha had impaired kidney function in a surveyOther study · 10 October 2026
- Triple agonist UBT251 lowered body weight over 24 weeks in a phase 2 trialRandomised trial · 10 October 2026